Patent
Described herein are Dendrilla membranosa compounds and derivatives thereof. Also described herein are formulations that can contain an amount of one or more Dendrilla membranosa compounds or derivatives thereof and a carrier. Also described herein are methods of administering one or more Dendrilla membranosa compound and/or derivative thereof or a formulation thereof to a subject in need thereof.
1. A method of treating an infection in a subject, the method comprising administering to the subject an effective amount of darwinolide compound having a formula of:
wherein the infection is a bacterial infection.
2. The method of claim 1 , wherein the bacterial infection is caused by MRSA.
3. The method of claim 1 , wherein the bacterial infection is caused by bacteria that form a bacterial biofilm.
4. The method of claim 3 , wherein the bacterial biofilm is a MRSA bacterial biofilm.
5. The method of claim 3 , wherein the darwinolide compound inhibits bacterial biofilm formation.
6. The method of claim 1 , wherein the darwinolide compound is combined with a pharmaceutically acceptable carrier.
7. The method of claim 6 , wherein the darwinolide compound and pharmaceutically acceptable carrier is administered orally, intravenously, trans-dermally, or topically.
8. The method of claim 7 , wherein the darwinolide compound and pharmaceutically acceptable carrier is administered topically.
9. The method of claim 8 , wherein the darwinolide compound and pharmaceutically acceptable carrier is administered topically to an area of the skin and/or mucous membrane infected by MRSA.